Identification of resistance mutations to crizotinib through circulating tumor cell (CTC) analysis in ALK-rearranged non-small-cell lung cancer (NSCLC)

被引：0

作者：

Pailler, Emma ^{[1
]}

Faugeroux, Vincent ^{[1
]}

Oulhen, Marianne ^{[2
]}

Forcato, Claudio ^{[3
]}

Laporte, Melanie ^{[4
]}

Lecluse, Yann ^{[4
]}

Lacroix, Ludovic ^{[4
]}

NgoCamus, Maud ^{[4
]}

Nicotra, Claudio ^{[4
]}

Remon, Jordi ^{[4
]}

Mezquita, Laura ^{[4
]}

Planchard, David ^{[4
]}

Soria, Jean-Charles ^{[4
]}

Manaresi, Nicolo ^{[3
]}

Besse, Benjamin ^{[4
]}

Farace, Francoise ^{[1
]}

机构：

[1] Univ Paris Saclay, Gustave Roussy, INSERM, U981, Villejuif, France

[2] INSERM, Gustave Roussy, U981, Villejuif, France

[3] Menarini Silicon Biosyst, Castel Maggiore, Italy

[4] Gustave Roussy, Villejuif, France

来源：

CANCER RESEARCH | 2018年 / 78卷 / 13期

关键词：

D O I：

10.1158/1538-7445.AM2018-3654

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

3654

引用

页数：2

共 50 条

[1] Acquired Resistance Mutations to ALK Inhibitors Identified by Single Circulating Tumor Cell Sequencing in ALK-Rearranged Non-Small-Cell Lung Cancer
Pailler, Emma
Faugeroux, Vincent
Oulhen, Marianne
Mezquita, Laura
Laporte, Melanie
Honore, Aurelie
Lecluse, Yann
Queffelec, Pauline
NgoCamus, Maud
Nicotra, Claudio
Remon, Jordi
Lacroix, Ludovic
Planchard, David
Friboulet, Luc
Besse, Benjamin
Farace, Francoise
CLINICAL CANCER RESEARCH, 2019, 25 (22) : 6671 - 6682
[2] Overcoming crizotinib resistance in ALK-rearranged non-small cell lung cancer
Qi, Xiaolong
Ma, Wang
Li, Sen
Zhou, Caicun
LUNG CANCER, 2014, 85 (02) : 335 - 336
[3] Xanthogranutomatous pyelonephritis complicating crizotinib treatment of an ALK-rearranged non-small-cell lung cancer
Brosseau, S.
Gounant, V.
Choudat, L.
Pluvy, J.
Zalcman, G.
Khalil, A.
DIAGNOSTIC AND INTERVENTIONAL IMAGING, 2018, 99 (04) : 267 - 268
[4] Ceritinib in ALK-Rearranged Non-Small-Cell Lung Cancer
Shaw, Alice T.
Kim, Dong-Wan
Mehra, Ranee
Tan, Daniel S. W.
Felip, Enriqueta
Chow, Laura Q. M.
Camidge, D. Ross
Vansteenkiste, Johan
Sharma, Sunil
De Pas, Tommaso
Riely, Gregory J.
Solomon, Benjamin J.
Wolf, Juergen
Thomas, Michael
Schuler, Martin
Liu, Geoffrey
Santoro, Armando
Lau, Yvonne Y.
Goldwasser, Meredith
Boral, Anthony L.
Engelman, Jeffrey A.
NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (13): : 1189 - 1197
[5] Ceritinib in ALK-Rearranged Non-Small-Cell Lung Cancer
Shen, Liang
Ji, Hong-Fang
NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (26): : 2537 - 2537
[6] Circulating tumor cell copy-number heterogeneity in ALK-rearranged non-small-cell lung cancer resistant to ALK inhibitors
Oulhen, Marianne
Pawlikowska, Patrycja
Tayoun, Tala
Garonzi, Marianna
Buson, Genny
Forcato, Claudio
Manaresi, Nicolo
Aberlenc, Agathe
Mezquita, Laura
Lecluse, Yann
Lavaud, Pernelle
Naltet, Charles
Planchard, David
Besse, Benjamin
Farace, Francoise
NPJ PRECISION ONCOLOGY, 2021, 5 (01)
[7] Circulating tumor cell copy-number heterogeneity in ALK-rearranged non-small-cell lung cancer resistant to ALK inhibitors
Marianne Oulhen
Patrycja Pawlikowska
Tala Tayoun
Marianna Garonzi
Genny Buson
Claudio Forcato
Nicolò Manaresi
Agathe Aberlenc
Laura Mezquita
Yann Lecluse
Pernelle Lavaud
Charles Naltet
David Planchard
Benjamin Besse
Françoise Farace
npj Precision Oncology, 5
[8] Tumor volume dynamics and tumor growth rate in ALK-rearranged advanced non-small-cell lung cancer treated with crizotinib
Nishino, Mizuki
Hida, Tomoyuki
Kravets, Sasha
Dahlberg, Suzanne E.
Lydon, Christine A.
Hatabu, Hiroto
Johnson, Bruce E.
Awad, Mark M.
EUROPEAN JOURNAL OF RADIOLOGY OPEN, 2020, 7
[9] Targeting ALK-rearranged non-small-cell lung cancer: an update
Sullivan, Ivana
Planchard, David
FUTURE ONCOLOGY, 2017, 13 (14) : 1213 - 1217
[10] Concomitant TP53 mutations with response to crizotinib treatment in patients with ALK-rearranged non-small-cell lung cancer
Song, Peng
Zhang, Fanshuang
Li, Yan
Yang, Guangjian
Li, Wenbin
Ying, Jianming
Gao, Shugeng
CANCER MEDICINE, 2019, 8 (04): : 1551 - 1557

← 1 2 3 4 5 →